This Is Too Hot For Lineage Cell Therapeutics Inc (AMEX: LCTX), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Most recently, Yahoo Finance reported about the stock as it publicized that Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

As a AMEX listed company, LCTX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Lineage Cell Therapeutics Inc is $275.25M. A total of 2.06 million shares were traded on the day, compared to an average of 921.75K shares.

In the most recent transaction, BAILEY DON M bought 96,155 shares of LCTX for 1.04 per share on Feb 08 ’24. After the transaction, the Director now owns 158,801 company shares. In a previous transaction on Feb 06 ’24, BROADWOOD PARTNERS, L.P. bought 6,730,770 shares at 1.04 per share. LCTX shares that Director owns now total 41,666,255.

Among the insiders who bought shares, Jayasuriya Anula acquired of 10,000 shares on Dec 29 ’23 at a per-share price of $1.09. This resulted in the Director holding 10,000 shares of LCTX after the transaction.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, LCTX has a high of $1.61 and a low of $0.84.

As of this writing, LCTX has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.05.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. LCTX’s latest balance sheet shows that the firm has $58.36M in Cash & Short Term Investments as of fiscal 2021. There were $2.80M in debt and $47.12M in liabilities at the time. Its Book Value Per Share was $0.36, while its Total Shareholder’s Equity was $90.90M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LCTX is Buy with a score of 4.71.

Most Popular

Related Posts